Rituximab, Methotrexate, Procarbazine, and Lomustine for Primary CNSL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma
Leukemia and Lymphoma 2022 May 02;[EPub Ahead of Print], E Lebel, N Goldschmidt, T Siegal, A Lossos, S Rosenberg, C Makranz, E Linetski, ME Gatt, A Gural, R Saban, D Lavie, V Vainstein, E Zimran, B Avni, S Grisaro, A Shaulov, B NachmiasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.